How to buy AppLovin (APP) stock from India

Yes, an Indian resident can buy AppLovin — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% is tax, estate-tax exposure, and — for a name that has rerated roughly 10x since 2023 — position sizing. APP has one helpful quirk: it pays no dividend, so US withholding and Form 67 paperwork are essentially a non-issue. This is the short version.

The 30-second version

• Legal and simple. Buy APP via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Given the share price, a fractional rupee amount is the sensible default.
• Pure capital-gains play. APP has never paid a dividend, so US withholding and Form 67 are essentially irrelevant.
• India tax: hold more than 24 months and pay 12.5% LTCG (no indexation); sell sooner and pay your slab rate. Section 112, not the friendlier 112A that Indian shares get.
• The trap most miss: directly-held APP is a US-situs asset — above 60,000 dollars, your estate faces up to 40% US estate tax, with no India-US treaty relief. At APP's price this threshold breaks fast.
• If your thesis is "US AI and digital ads," QQQ now holds APP at a meaningful weight after its Nasdaq-100 inclusion — same exposure, no single-stock risk.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	APP / Nasdaq
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact rupee amount)
Dividend	None — APP has never paid one and has no announced plan to start
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above 60,000 dollars means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). File your W-8BEN during onboarding — still good practice even with no current dividend. New to this? Start with how to invest in US stocks from India.
2. Fund via the LRS. Remit from your Indian bank under the LRS (cap: 250,000 dollars per financial year). 20% TCS applies above ten lakh rupees — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. One APP share now trades in the hundreds of dollars after the 2024-25 rerating, so most Indian investors use fractional orders rather than buying whole shares. No stock split as of late 2025.

The tax that actually matters

AppLovin pays no dividend, so the 25% US withholding and annual Form 67 dance — a recurring headache with names like Microsoft or Apple — does not apply here. Your entire tax exposure is on capital gains when you sell, under Section 112 (foreign shares don't get the friendlier 112A treatment Indian-listed equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy a fractional position equivalent to 2 shares at 350 dollars when USD/INR is 86 → cost 60,200 rupees. Sell 26 months later at 500 dollars when USD/INR is 88 → proceeds 88,000 rupees. Taxable gain 27,800 rupees; LTCG at 12.5% = 3,475 rupees. The gain is computed in rupees, so a weaker rupee at sale amplifies your reported gain — and APP's own volatility can swamp the FX move. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India. For Form 67 context, see dividend withholding and Form 67.

The 60,000 dollar estate-tax trap

Directly-held APP is a US-situs asset. If the holder dies with more than 60,000 dollars of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. At APP's price, even a modest position breaches this threshold once combined with other US holdings. The fix (pooled or fund structures rather than direct shares) has to be a deliberate choice made before the position gets large. Full detail: the 60,000 dollar estate-tax trap.

Buy the stock, or get AppLovin through an ETF?

If you want…	Best route
A concentrated bet that APP keeps compounding ad-spend share	APP directly
"US digital-ads and AI will keep winning" exposure	QQQ (APP now sits at a meaningful weight post Nasdaq-100 inclusion)
A diversified digital-ads / momentum tilt	A digital-advertising or momentum-factor ETF
The least single-stock risk	A broad ETF

After its Nasdaq-100 inclusion, QQQ now holds APP at a non-trivial weight alongside the megacap digital-ads complex (Google, Meta, Amazon). Digital-advertising and momentum-factor ETFs offer a diversified version of the same thesis — better ad-targeting capturing more marketing spend — without the single-name fragility. Compare the routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: AppLovin is now a pure-play AI advertising company. Its AXON engine uses machine learning to match ads to users at scale, originally inside mobile games but, from 2024, expanding into e-commerce ads — a self-serve channel competing with Google and Meta. The legacy mobile-gaming portfolio was sold to Tripledot in 2025, leaving APP as a software-and-platform business with very high incremental margins.

Bull case	Bear case
AXON's ad-targeting reportedly outperforms incumbents on advertiser ROI	Short-seller reports in early 2025 questioned attribution methodology and flagged "circular ad spend" concerns
E-commerce ad expansion opens a multi-billion incremental TAM beyond gaming	Extreme valuation — roughly 50x forward earnings leaves little margin for error
Gaming portfolio sold to Tripledot, focusing the company on pure-play adtech	Regulatory risk on iOS and Android privacy changes could blunt targeting
Very high incremental margins on each new advertiser dollar	Customer-concentration in mobile gaming clients
Structural tailwind as third-party cookies fade and others lose signal	Key-person risk around CEO Adam Foroughi

Exact valuation is in the live widget above — adtech priced for near-flawless execution.

Our take

Verdict: HOLD / Watch — the fundamental thesis is real, but the rerating has compressed forward returns and raised the bar for every print.

• The thesis is genuine. Better targeting drives advertiser ROI, which earns AXON a larger share of ad budgets, which the platform's margin structure converts to operating leverage. E-commerce ads widen the TAM beyond gaming.
• But the price already reflects it. A 10x move since 2023 means the stock embeds years of flawless execution. A single soft quarter, a privacy-rule change, or a credible competitive response from Google or Meta could compress the multiple sharply.
• Treat it as a momentum / growth satellite, not a defensive holding. Size it small enough that a 40-50% drawdown is uncomfortable but not portfolio-defining. The clean tax profile makes APP easy to own; what's hard is deciding how much.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Valuation = expectation = fragility. At roughly 50x forward earnings, APP is priced for continued share gains. A single quarter where revenue growth or take-rate disappoints can trigger sharp compression — 30-50% drawdowns in growth-adtech names on weak prints are historically common.
• Methodology scrutiny. Short-seller reports in early 2025 raised questions about attribution and certain ad-spend patterns. Management has pushed back and financials continue to print well; follow subsequent disclosures yourself.
• Platform and privacy risk. Apple and Google control the privacy frameworks AXON operates within; an unfavourable change to ad identifiers could blunt targeting.
• Competitive replication. AI ad-targeting is not a permanent moat. Google and Meta have larger first-party data sets; a credible AXON-equivalent from a megacap would re-rate APP fast.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose APP in Schedule FA every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. No dividend means you skip Form 67 — but Schedule FA is non-negotiable. Use the Schedule FA helper.
• Position size: a single high-multiple growth name is not an index. After a 10x-plus move, the maths of staying disciplined matters more than being right — trim into strength so a single rough quarter cannot derail the portfolio.

Bottom line

Buying APP from India is easy and legal. What needs thought is that APP is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a 60,000 dollar estate-tax trap that bites quickly at this price, and a high-multiple single name that needs disciplined position sizing. No dividend means no recurring withholding and no Form 67 work. If your real thesis is "AI is changing digital advertising," QQQ or a digital-ads ETF gives meaningful APP exposure plus diversification across the rest of the ad complex. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.